Page last updated: 2024-10-28

hydroxyurea and Renal Insufficiency

hydroxyurea has been researched along with Renal Insufficiency in 3 studies

Renal Insufficiency: Conditions in which the KIDNEYS perform below the normal level in the ability to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism. Renal insufficiency can be classified by the degree of kidney damage (as measured by the level of PROTEINURIA) and reduction in GLOMERULAR FILTRATION RATE.

Research Excerpts

ExcerptRelevanceReference
"Patients with sickle cell anemia are at risk for organ damage including kidney disease."1.37Protective role of hemoglobin and fetal hemoglobin in early kidney disease for children with sickle cell anemia. ( Askenazi, DJ; Hilliard, LM; Howard, TH; Johnson, SM; Lebensburger, J; Rozario, NL, 2011)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lebensburger, J1
Johnson, SM1
Askenazi, DJ1
Rozario, NL1
Howard, TH1
Hilliard, LM1
Miras Parra, FJ1
Salvatierra Ossorio, J1
Gómez Jiménez, FJ1
de la Higuera Torres-Puchol, J1
Bendele, RA1
Richardson, FC1

Other Studies

3 other studies available for hydroxyurea and Renal Insufficiency

ArticleYear
Protective role of hemoglobin and fetal hemoglobin in early kidney disease for children with sickle cell anemia.
    American journal of hematology, 2011, Volume: 86, Issue:5

    Topics: Adolescent; Albuminuria; Anemia, Sickle Cell; Biomarkers; Blood Transfusion; Child; Early Diagnosis;

2011
[Treatment of essential thrombocytopenia associated with severe renal insufficiency].
    Revista clinica espanola, 1996, Volume: 196, Issue:8

    Topics: Humans; Hydroxyurea; Male; Middle Aged; Renal Insufficiency; Severity of Illness Index; Thrombocytop

1996
Adefovir nephrotoxicity and mitochondrial DNA depletion.
    Human pathology, 2002, Volume: 33, Issue:5

    Topics: Adenine; Antiviral Agents; Clinical Trials, Phase III as Topic; Cyclooxygenase Inhibitors; DNA, Mito

2002